Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Appili Therapeutics Inc T.APLI

Alternate Symbol(s):  APLIF

Appili Therapeutics Inc. is a biopharmaceutical company. The company is engaged in novel antibiotic and anti-infective therapies to help... see more


Bullboard (TSX:APLI)

View:
Post by opsd1on Nov 21, 2022 1:20pm

Big bids coming in now.

What's up?
Post by opsd1on Nov 15, 2022 10:14am

APLI Secures US$14 million from US DoD for Biodefense

Appili Therapeutics ATI-1701 Biodefense Vaccine Secures ~US$14 Million of Funding from the U.S. Department of Defense in Partnership with the U.S. Air Force Academy https://stockhouse.com/news/press ...more  

Cedar Clinical Research, by Numinus, the top enrolling clinical research site for MindMed's Phase 2B study evaluating MM-120

"We're excited to support MindMed in their clinical trial work, by evaluating new important treatments and protocols to address mental health disorders...The fact that our Draper research clinic is the top enrolling site for the study underscores the quality of our clinical research capabilities and recruiting efforts ...read more
Post by bmreedon Apr 14, 2022 3:47pm

News Update w Radius Research and $APLI CEO Armand Balboni

News Update: Appili Therapeutics (APLI) w CEO Dr. Armand Balboni  - Develop Leishmaniasis Treatment ATI-1801 - https://www.youtube.com/watch?v=YyE8zLvWApM {^youtubevideo|(width)425 ...more  
User Avatar Image
(10)
•••
  • ecanadian2X
Post by ecanadian2on Apr 12, 2022 8:25pm

yes, lots of potential and appears to be a well run

company but: * $3.6M they raised will be used almost in full to pay off the previous loan * the interest on the new loan will be at least $1/4 million a year ... and APLI has precious little money on ...more  
Post by bmreedon Apr 11, 2022 10:32am

Webinar Recap w Radius Research & $APLI CEO Armand Balboni

Webinar Recap: Appili Therapeutics (APLI) w CEO Dr. Armand Balboni - Drug Development Focused on Infectious Diseases - Pitch, Deep Dive, and Q&A - https://www.youtube.com/watch?v=xGrmHACzU7c  ...more  
Post by bmreedon Apr 04, 2022 10:25am

Webinar w $APLI CEO Armand Balboni Fri Apr 8 @ 12:30PM ET

Webinar - Appili Therapeutics (APLI) w/ CEO Dr. Armand Balboni Fri, Apr 8 at 12:30pm ET / 9:30am PT Q&A with Radius Research  Register Here - https://us02web.zoom.us/webinar ...more  
User Avatar Image
(369)
•••
  • Betteryear2X
Post by Betteryear2on Mar 29, 2022 2:23pm

Appili Therapeutics Announces Non-Convertible Secured Loan

March 29, 2022 07:36 AM Eastern Daylight Time HALIFAX, Nova Scotia--(BUSINESS WIRE)--Appili Therapeutics Inc. (TSX: APLI; OTCQX: APLIF) (the “Company” or “Appili”), a biopharmaceutical company ...more  
User Avatar Image
(10)
•••
  • ecanadian2X
Post by ecanadian2on Mar 16, 2022 12:37am

Will Lind be converting $3 mil into shares after Mar 18?!!

Will Lind be converting $3 million into shares after Friday March 18?! That would be 10s of millions of shares unloaded on the illiquid APLI market. Scary ... still no update from APLI on this. " ...more  

Thematica Insights Report and Investor Guide

Beyond Precious

An investor's guide to precious metals and their potential in today's market. Click here to access the report.
User Avatar Image
(369)
•••
  • Betteryear2X
Post by Betteryear2on Feb 28, 2022 7:58am

Over US$10 M in New Funding from US Department of Defense

February 28, 2022 07:40 AM Eastern Standard Time HALIFAX, Nova Scotia--(BUSINESS WIRE)--Appili Therapeutics Inc. (TSX: APLI; OTCQX: APLIF) (the “Company” or “Appili”), a biopharmaceutical ...more  
User Avatar Image
(369)
•••
  • Betteryear2X
Post by Betteryear2on Feb 08, 2022 7:27am

Appili Therapeutics Expands ATI-1501 Commercial Agreement

February 08, 2022 07:17 AM Eastern Standard Time HALIFAX, Nova Scotia--(BUSINESS WIRE)--Appili Therapeutics Inc. (TSX: APLI; OTCQX: APLIF) (the “Company” or “Appili”), a biopharmaceutical ...more  
User Avatar Image
(16)
•••
  • kindvalueX
Comment by kindvalueon Dec 20, 2021 2:48pm

RE:Isn't this essentially an investment banker's "house play"?

investment bankers running companies equals failure in particular BB : TMD  VIV  APLI  MIMI ATE  GTMS Oh and their great cannabis deal that was a fraud TRST 
User Avatar Image
(800)
•••
  • SouthernTierTomX
Post by SouthernTierTomon Dec 18, 2021 3:10pm

Isn't this essentially an investment banker's "house play"?

I LOVE it here! JMHO Do you own due diligence always!
User Avatar Image
(16)
•••
  • kindvalueX
Post by kindvalueon Dec 17, 2021 2:56pm

INSIDERS

instead of insider buying they issue a stack of $0.13 warrants  not a way to regain credibility  companies controlled by investment bankers is not a great recipe 
User Avatar Image
(369)
•••
  • Betteryear2X
Post by Betteryear2on Nov 19, 2021 7:46am

Positive One Year Challenge Results

November 19, 2021 07:42 AM Eastern Standard Time HALIFAX, Nova Scotia--(BUSINESS WIRE)--Appili Therapeutics Inc. (TSX:APLI; OTCQX: APLIF) (the “Company” or “Appili”), a biopharmaceutical company ...more  
Post by mingzhuon Nov 12, 2021 9:19pm

new drug trial coming in Dec

Preparing for ATI-2307 clinical trial drug product GMP manufacturing runs to be initiated in December 2021. https://ca.finance.yahoo.com/news/appili-therapeutics-reports-financial ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >